Content about Rosiglitazone

April 12, 2011

A point-of-sale safety check may reduce the risk of patients unsafely receiving a drug for Type 2 diabetes that may increase their risk of heart attack, according to a new study conducted by pharmacy benefit manager Prime Therapeutics and scheduled for presentation at the 23rd annual meeting of the Academy of Managed Care Pharmacy in Minneapolis.

March 18, 2011

With respect to the Type 2 diabetes drug Avandia, British drug maker GlaxoSmithKline has another medical study to worry about.

February 14, 2011

GlaxoSmithKline has changed prescribing information on the labeling for one of its Type 2 diabetes drugs to reflect new restrictions on the drug’s use, the drug maker said.

January 17, 2011

Drug maker GlaxoSmithKline will take a legal charge of $3.4 billion related to its promotion of a controversial diabetes drug.

September 22, 2010

The Food and Drug Administration has moved to significantly restrict access to a controversial diabetes...

September 16, 2010

The Food and Drug Administration said Friday it had begun a safety review of Takeda’s...

August 26, 2010

According to a recent study published in the science journal PloS One, eating grapefruit could...

July 14, 2010

A joint advisory committee of the Food and Drug Administration has voted to recommend allowing...

February 22, 2010

The Food and Drug Administration is reviewing data from a large clinical study of a...

February 21, 2010

A report released over the weekend by a Senate committee linked a drug used to...

February 10, 2010

Women with Type 2 diabetes who take a commonly prescribed class of medications to treat...

© 2013 Drug Store News. All Rights Reserved.